Life settlement carrier concentration 2026: top 5 issuers, AM Best trajectory, and the 3-tier risk framework.
Most carrier articles cover product reviews for individual policy buyers. This article analyzes the top 5 carriers in U.S. life settlement secondary market supply from buy-side institutional perspective — Lincoln National, Pacific Life, John Hancock, Prudential, and MassMutual.
The top 5 carriers most commonly issuing policies that flow into the U.S. life settlement secondary market are Lincoln National, Pacific Life, John Hancock (Manulife), Prudential, and MassMutual. All five maintain AM Best ratings of A or A+ as of 2026, but each presents distinct concentration considerations for institutional buy-side investors — cost-of-insurance schedule histories, product line evolution, M&A activity (John Hancock's 2013 individual annuity exit, Voya/Equitable/Brighthouse runoff blocks), and reinsurance structures all affect long-term claim payment risk. Buy-side concentration management typically applies a 3-tier framework: single-carrier maximum exposure (25-35% of portfolio), cross-carrier diversification minimum (4+ carriers per portfolio), and product line mix limits. Invest in life settlements through HYV in the institutional segment where carrier-level diligence is built into every opportunity.
Carrier concentration is one of the least-discussed but most consequential dimensions of life settlement portfolio risk management. Most investor-facing content focuses on policy-level analysis — LE estimates, premium projections, target IRR. But the institutional buy-side experience is that concentration risk operates at the carrier level: when a carrier experiences a credit event, regulatory issue, or product withdrawal, every policy in that portfolio with that carrier becomes simultaneously affected. After more than two decades executing carrier-level diligence across hundreds of transactions, the framework below organizes the top 5 issuers and the 3-tier concentration management approach that distinguishes institutional from amateur portfolio construction.
Why carrier concentration matters for buy-side investors
Most public market alternative asset concentration discussions focus on issuer concentration in credit portfolios or sector concentration in equity portfolios. Life settlement portfolios present a distinct concentration dimension because the carrier — not the insured — is the entity responsible for paying the death benefit at maturity. A policy in a buy-side portfolio is effectively a claim against the carrier's ability to fund the death benefit when the insured passes.
Three structural mechanisms create carrier concentration risk operationally. First, cost-of-insurance schedule changes affect every in-force policy issued by that carrier simultaneously. When Lincoln National adjusted its COI schedules in 2016 across a portion of its universal life book, every buy-side investor holding those policies faced compressed projected returns from accelerated premium load. The concentration mechanism is structural, not idiosyncratic.
Second, AM Best rating changes affect the entire carrier's outstanding book. A downgrade from A to A- across a carrier's life insurance subsidiary cascades into every in-force policy that subsidiary issued. While most major carriers maintain stable ratings over multi-year periods, the cumulative impact of carrier-level credit events on a concentrated portfolio can be substantial.
Third, regulatory and product withdrawal events introduce administrative complexity. John Hancock's 2013 exit from individual annuity sales did not affect in-force life insurance policies directly, but it required investors with concentrated Hancock exposure to evaluate the parent company's long-term commitment to the U.S. life insurance business. Similar considerations apply to Voya, Brighthouse, Lincoln Benefit Life runoff blocks, and other carriers with strategic shifts.
For institutional buy-side investors, the practical implication is that policy-level diligence is necessary but not sufficient. Carrier-level concentration management is the second layer of portfolio construction discipline.
The top 5 carriers — institutional profile analysis
The five carriers below appear most frequently in U.S. life settlement secondary market supply based on industry transaction data. The profile for each covers AM Best rating as of 2026 publication, concentration tier categorization for portfolio construction purposes, brief COI schedule history, and notable considerations for buy-side investor diligence.
Lincoln National
Pacific Life
John Hancock (Manulife)
Prudential Financial
MassMutual
Beyond the top 5, the broader U.S. life settlement secondary market draws supply from approximately 20-25 active carriers including New York Life, Northwestern Mutual, Nationwide, Transamerica, Symetra, Penn Mutual, Mutual of Omaha, Securian, AXA/Equitable, Brighthouse (legacy MetLife book), Voya, and others. Each carrier presents distinct concentration considerations; institutional buy-side portfolios typically balance exposure across the top 5 anchor carriers plus selective additions from the broader carrier universe.
Approximate share of U.S. life settlement secondary market policy supply concentrated in the top 5 carriers (Lincoln National, Pacific Life, John Hancock, Prudential, MassMutual). This high concentration is structural — it reflects these carriers' historical U.S. life insurance issuance volume — and creates the practical need for the 3-tier concentration management framework. See AM Best for current carrier financial strength ratings.
The 3-tier concentration risk framework
Institutional buy-side concentration management typically applies a three-tier framework that operates simultaneously at the single-carrier level, the cross-carrier diversification level, and the product line mix level. Each tier addresses a distinct concentration risk dimension; together they produce a disciplined approach to portfolio construction.
Single-carrier · cross-carrier · product line mix
Single-carrier maximum exposure
No single carrier exceeds 25-35% of portfolio face value. Even when a Tier 1 anchor carrier (Lincoln, Pacific Life, Hancock, Prudential, MassMutual) appears in multiple attractive opportunities, the cap prevents over-concentration that would amplify carrier-specific credit, regulatory, or COI events.
Cross-carrier diversification minimum
Minimum 4-5 different carriers represented in portfolio. Cross-carrier diversification reduces sensitivity to any single carrier event. Smaller portfolios (sub-$5M) may benefit from concentration in top 3-4 anchor carriers; larger portfolios benefit from broader carrier mix including Tier 2/3 issuers.
Product line mix limits
Maximum 60% in any single product type (universal life, whole life, IUL, GUL). Different product lines carry different COI variability profiles, lapse risk patterns, and carrier servicing approaches. Product line diversification reduces sensitivity to any single product-class event affecting multiple positions.
The framework operates as guidance rather than rigid rule. Concentration limits may be appropriately relaxed for portfolios with specific strategic objectives (e.g., concentrating in MassMutual mutual-structure whole life for stability) or appropriately tightened for portfolios with specific risk constraints (e.g., further diversification for institutional fiduciary mandates). The framework provides the operational baseline that institutional buy-side construction typically returns to.
Browse vetted life settlement opportunities
HYV opportunities arrive with carrier-level analysis — AM Best rating verification, COI history review, product line classification — supporting accredited investor portfolio construction discipline.
Browse the platformCOI schedule history and forward considerations
Cost-of-insurance (COI) schedule history is the single most consequential carrier-specific dimension for buy-side investors because premium projections through projected LE directly drive pricing math. Each carrier's COI adjustment pattern provides forward-looking signal about premium burden risk during the holding period.
- Lincoln National 2016 adjustments affected a portion of universal life book; in-force policies issued in earlier cohorts experienced premium increases that compressed buy-side IRR projections. Buy-side diligence on Lincoln-issued policies should verify the specific contract series and any post-acquisition adjustment notification rights.
- Phoenix Life (post-2014) had multiple rounds of COI adjustments before reorganization. Older Phoenix-issued policies in secondary market supply warrant specific contract-level review.
- AXA/Equitable made notable COI adjustments on certain universal life products historically. Buy-side diligence should review specific contract type and adjustment provisions.
- Pacific Life and MassMutual generally maintain favorable COI stability profiles; both carriers represent more predictable premium load patterns for buy-side projection accuracy.
- Forward consideration: secular mortality improvement may create incremental pressure on COI schedules across the industry. Carriers with mortality-favorable existing books may face less adjustment pressure than those with adverse experience.
For institutional investors who invest in life settlement policies through HYV, every opportunity arrives with carrier-level documentation including AM Best rating verification, COI schedule history review specific to the contract type, and product line classification — supporting the 3-tier concentration management framework at the portfolio construction layer.
Invest in life settlements with carrier concentration transparency
HYV opportunities include AM Best rating verification, COI schedule history specific to the contract type, and product line classification — supporting accredited investor portfolio construction discipline.
The top 5 carriers most commonly issuing policies that flow into the U.S. life settlement secondary market — Lincoln National Life, Pacific Life Insurance Company, John Hancock Life Insurance Company (a subsidiary of Manulife Financial), Prudential Financial, and MassMutual — account for approximately 60-70% of buy-side supply based on industry transaction data. All five maintain AM Best ratings of A or A+ as of 2026 publication; MassMutual maintains A++. Carrier-specific COI schedule history includes Lincoln National's 2016 adjustments across a portion of universal life book, Phoenix Life's pre-reorganization adjustments, and AXA/Equitable's historical adjustments on certain universal life products. Current AM Best financial strength ratings and rating outlook are published by AM Best; carrier financial statements and supplementary information are filed with state insurance regulators and the NAIC.
The 3-tier concentration management framework operates at single-carrier maximum exposure (typically 25-35% of portfolio face value), cross-carrier diversification minimum (4-5 different carriers represented), and product line mix limits (maximum 60% in any single product type — universal life, whole life, IUL, GUL). The framework reflects general institutional buy-side construction discipline; specific application varies by portfolio size, strategic objectives, and risk constraints. Smaller portfolios (sub-$5M) may concentrate in top 3-4 anchor carriers; larger portfolios benefit from broader carrier mix. Product line classification follows standard industry taxonomy with carrier-specific contract type designations.
Beyond the top 5, the broader U.S. life settlement secondary market draws supply from approximately 20-25 active carriers including New York Life, Northwestern Mutual, Nationwide, Transamerica, Symetra, Penn Mutual, Mutual of Omaha, Securian, AXA/Equitable, Brighthouse (legacy MetLife book), Voya, and others. Each carrier presents distinct concentration considerations. Industry market data, transaction statistics, and carrier participation context are published by the Life Insurance Settlement Association (LISA) and Conning Research strategic studies. The U.S. life settlement market transacts approximately $4.6 billion annually against $224 billion in addressable supply per Conning Research estimates. Federal investor accreditation under SEC Rule 501 of Regulation D applies to all life settlement direct-ownership investments regardless of carrier composition.
Invest in life settlements through institutional infrastructure
HYV opportunities arrive with carrier-level analysis supporting the 3-tier concentration management framework — AM Best rating verification, COI history review, and product line classification documented per position.
Frequently asked questions
Which carriers dominate U.S. life settlement secondary market supply?
The top 5 carriers most commonly issuing policies that flow into the U.S. life settlement secondary market are Lincoln National Life, Pacific Life Insurance Company, John Hancock Life Insurance Company (a subsidiary of Manulife Financial), Prudential Financial, and MassMutual. These five carriers collectively account for approximately 60-70% of buy-side supply based on industry transaction data, reflecting their historical share of U.S. life insurance issuance volume. Beyond the top 5, the broader market draws supply from approximately 20-25 active carriers including New York Life, Northwestern Mutual, Nationwide, Transamerica, Symetra, Penn Mutual, Mutual of Omaha, Securian, AXA/Equitable, Brighthouse, and Voya, among others.
What AM Best ratings do the top carriers maintain?
As of 2026 publication, all top 5 carriers maintain AM Best ratings in the A or A+ tier or higher: Lincoln National (A+), Pacific Life (A+), John Hancock/Manulife (A+), Prudential (A+), and MassMutual (A++ — the highest tier). MassMutual's A++ reflects its mutual insurance company structure and conservative balance sheet management. AM Best financial strength ratings indicate the carrier's ability to meet ongoing policyholder obligations including death benefit payments. Current ratings and rating outlook are published by AM Best directly; investor diligence should verify ratings at the time of each acquisition rather than relying on prior-period documentation.
How does carrier concentration affect portfolio risk?
Carrier concentration creates structural portfolio risk because when a carrier experiences a credit event, regulatory issue, COI schedule adjustment, or product withdrawal, every policy in the portfolio issued by that carrier becomes simultaneously affected. Unlike idiosyncratic policy-level risk (LE outcome variance, individual policy lapse), carrier-level risk operates across all positions with that issuer. The 3-tier concentration management framework addresses this through single-carrier maximum exposure (25-35% cap), cross-carrier diversification minimum (4-5 different carriers), and product line mix limits (60% maximum in any single product type). Concentration management is the second layer of portfolio construction discipline beyond policy-level diligence.
What are typical concentration limits for life settlement portfolios?
Institutional buy-side concentration management typically applies three tiers of limits: (1) single-carrier maximum exposure of 25-35% of portfolio face value — preventing over-concentration even when a Tier 1 anchor carrier appears in multiple attractive opportunities; (2) cross-carrier diversification minimum of 4-5 different carriers represented in the portfolio — reducing sensitivity to any single carrier event; (3) product line mix limits of maximum 60% in any single product type (universal life, whole life, IUL, GUL) — addressing distinct COI variability profiles and lapse risk patterns across product lines. These limits operate as guidance rather than rigid rule; specific application varies by portfolio size, strategic objectives, and fiduciary constraints. Smaller portfolios may benefit from concentration in top anchor carriers; larger portfolios benefit from broader diversification.
What is a COI schedule and why does it matter?
Cost-of-insurance (COI) schedule is the carrier's pricing structure for the mortality charge embedded in universal life and similar permanent life insurance products. Carriers retain contractual authority to adjust COI schedules within policy limits in response to mortality experience, expense trends, and regulatory changes. For buy-side investors holding these policies, COI schedule adjustments directly affect premium projections through the holding period — accelerated COI compresses realized IRR by increasing premium load. Carrier-specific COI history provides forward-looking signal about premium burden risk. Lincoln National's 2016 adjustments and Phoenix Life's pre-reorganization adjustments are notable examples; Pacific Life and MassMutual generally maintain more stable COI patterns. Buy-side diligence should review carrier-specific COI adjustment history for any policy under consideration.
How did John Hancock's 2013 individual annuity exit affect life policies?
John Hancock's 2013 exit from U.S. individual annuity sales did not directly affect in-force life insurance policies. The exit was specific to the annuity product line; life insurance issuance has continued. Manulife (parent company) maintains its commitment to U.S. life insurance business including ongoing servicing of in-force policies and new policy issuance. However, the strategic withdrawal from annuity sales did require buy-side investors with concentrated Hancock exposure to evaluate the parent company's long-term commitment to U.S. life insurance broadly. Similar strategic considerations apply to other carriers with product line exits, runoff blocks (Voya, Brighthouse legacy MetLife book), or M&A activity affecting in-force policy administration.
Does MassMutual's mutual structure provide a distinctive credit profile?
Yes. MassMutual's mutual insurance company structure — where policyholders are the owners rather than separate equity shareholders — produces a distinctive credit and product profile compared to publicly-traded carriers. Mutual structures typically maintain conservative balance sheets, longer investment horizons, and policyholder-aligned product economics. MassMutual maintains the highest AM Best rating (A++) of the top 5 life settlement supply carriers, reflecting this structural advantage. For buy-side investors seeking stability and predictable COI patterns, MassMutual-issued policies often represent favorable additions to portfolio construction. Similar considerations apply to other mutual carriers including New York Life, Northwestern Mutual, and Guardian Life — though concentration limits still apply at the carrier level.
How does HYV apply carrier concentration management?
High Yield Vault applies carrier-level diligence to every opportunity before presentation to accredited investors. Documentation includes AM Best financial strength rating verification at the time of acquisition, COI schedule history review specific to the contract type, product line classification, and any carrier-specific considerations (M&A activity, runoff status, prior COI adjustments). For investors building multi-policy portfolios, HYV's institutional framework supports the 3-tier concentration management approach — single-carrier exposure caps, cross-carrier diversification minimums, and product line mix limits. Across 21 years of practice and 438 accredited investors served, this carrier-level discipline has been built specifically to support institutional buy-side portfolio construction standards.
